Immune Reconstitution After Allo-HSCT and Blinatumomab

Clinical trial NCT06075212 · UNKNOWN

Trial details

NCT number: NCT06075212
Sponsor: Sichuan University
Status: UNKNOWN
Study type: OBSERVATIONAL

Leukemia, Lymphoid

Start date: 2023-10-01
Primary completion: 2024-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.